DNA Dollars

Stanford University is taking in money from the explosion in genetic engineering technology.

The university has already gained more than $2 million from companies that use university held patents on gene splicing techniques and two weeks ago added another client to its growing lists.

Creative BioMolecules, Inc, by paying a $10,000 licensing fee, became the 69th genetic engineering company entitled to use the university's patented DNA cloning methods.

And there's more. In addition to the flat $10,000 licensing fee, the university receives a small percentage of revenues resulting from all commercial applications of the licensing techniques. Net proceeds from the licensing are split between Stanford and the University of California, said Katherine Ku, who administers the DNA cloning license for Stanford's Office of Technology Licensing. The Stanford Daily